HELIUS MED TECHNOLOGIES INC's ticker is HSDTXXXX and the CUSIP is 42328V504. A total of 35 filers reported holding HELIUS MED TECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $3,000 | -50.0% | 2,015 | -25.1% | 0.00% | – |
Q2 2019 | $6,000 | -81.8% | 2,691 | -44.5% | 0.00% | – |
Q1 2019 | $33,000 | -23.3% | 4,848 | +3.4% | 0.00% | – |
Q4 2018 | $43,000 | -2.3% | 4,690 | +4.8% | 0.00% | – |
Q3 2018 | $44,000 | +100.0% | 4,477 | +91.2% | 0.00% | – |
Q2 2018 | $22,000 | – | 2,342 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rovida Advisors Inc. | 1,292,690 | $1,254,000 | 0.07% |
ISTHMUS PARTNERS, LLC | 204,829 | $199,000 | 0.04% |
Virtu Financial LLC | 85,388 | $83,000 | 0.01% |
Good Life Advisors, LLC | 10,811 | $10,000 | 0.00% |
UBS Group AG | 19,850 | $19,000 | 0.00% |
Sowell Financial Services LLC | 1 | $0 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 15 | $15,000 | 0.00% |
Advisor Group, Inc. | 20 | $0 | 0.00% |
US BANCORP \DE\ | 500 | $0 | 0.00% |